Soft tissue infections and the diabetic foot

American Journal of Surgery

Volumn 172, Issue 6 A, 1996, Pages 7s-12s

  Smith, Andrew J ^a   Daniels, Timothy ^a   Bohnen, John M A ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CLINDAMYCIN; CLOXACILLIN; GENTAMICIN; IMIPENEM; MEROPENEM; METRONIDAZOLE; NETILMICIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIMENTIN; TOBRAMYCIN;

BACTERIAL COLONIZATION; CONFERENCE PAPER; DEBRIDEMENT; DIABETIC FOOT; DIAGNOSTIC APPROACH ROUTE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LEG ULCER; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SOFT TISSUE INFECTION;

EID: 0030468655     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(96)00344-3     Document Type: Conference Paper

References (26)

1. McHenry CR, Malangoni MA. Necrotizing soft tissue infections. In: Fry DE, ed. Surgical Infections. Boston: Little, Brown; 1995:161-8.
2. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med. 1989;321:1-7.
3. Henriksen BM, Albrektsen SB, Simper LB, Gutschik E. Soft tissue infections from drug abuse. A clinical and microbiologic review of 145 cases. Acta Orthopaed Scand. 1994;65:625-8.
4. Sutherland ME, Meyer AA. Necrotizing soft tissue infections. Surg Clin North Am. 1994;74:591-607
5. Lille ST, Sato TT, Engrav LH, et al. Necrotizing soft tissue infections: obstacles in diagnosis. J Am Coll Surg. 1996;182:7-11.
6. Dellinger EP. Severe necrotizing soft tissue infections. JAMA. 1981;246:1717-21.
7. Bohnen JMA. Managing spreading soft tissue infections. Perspect Emerg Care. 1986;1:50-9.
8. Ahrenholtz DH. Necrotizing soft-tissue infections. Surg Clin North Am. 1988;68:199-214.
9. Loyer EM, DuBrow RA, David CL, et al. Imaging of superficial soft-tissue infections: sonographic findings in cases of cellulitis and abscess. Am J Roentgen. 1996;166:149-52.
10. Beltran J. MR imaging of soft-tissue infection. Mag Res Clin North Am. 1995;3:743-51.
11. Beauchamp NJ, Scott WW, Gottlieb LM, Fishman EK. CT evaluation of soft tissue and muscle infection and inflammation: a systematic compartmental approach. Skeletal Radiol. 1995;24:317-24.
12. Stamenkovic I. Early recognition of potentially fatal necrotizing fasciitis. N Engl J Med. 1984;310:1689-93
13. Guiliano A, Lewis F, Hadley K, Blaisdell FW. Bacteriology of necrotizing fasciitis. Am J Surg. 1977;134:52-7.
14. Bretzke ML, Bubrick MP, Hitchcock CR. Diffuse spreading clostridium septicum infection, malignant disease and immune suppression. Surg Gynecol Obstet. 1988;166:197-200.
15. Sanford JP, Gilbert DN, Sande MA. Guide to Antimicrobial Therapy. Dallas: Antimicrobial Therapy Inc., 1995.
16. Tassler H, Cullmann W, Elhardt D. Therapy of soft tissue infections with piperacillin/tazobactam. J Antimicrob Chemother. 1993;31(suppl):105-12.
17. Tan JS, Wishnow RM, Talan DA, et al. The piperacillin/tazobactam skin and skin structure study group. Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multi-center study of piperacillin-tazobactam versus ticarcillin-clavulanate. Antimicrob Agents Chemother. 1993;37:1580-6.
18. Pitkin D, Shiekh W, Wilson S, et al. Comparison of the activity of meropenam with that of other agents in the treatment of intraabdominal, obstetric/gynecologic, and skin and soft tissue infection. Clin Infect Dis. 1995;20(suppl):372-5.
19. Brown DR, Davis NL, Lepawsky M, et al. A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg. 1994;167:485-9.
20. Stevens DL, Bryant AE, Adams K, Mader JT. Evaluation of therapy with hyperbaric oxygen for experimental infection with clostridium perfringens. Clin Infect Dis. 1993;17:231-7.
21. Lamothe F, D'Amico P, Ghosn P, et al. Clinical usefulness of intravenous human immunoglobulins in invasive group A streptococcal infections: case report and review. Clin Infect Dis. 1995;21:1469-71.
22. Colwell J, Lyons T, Klein R, Lopes-Virella M. New concepts about the pathogenesis of atherosclerosis and thrombosis in diabetes mellitus. In: Levin M, O'Neal L, Bowker J, eds. The Diabetic Foot, 5th ed. St. Louis: Mosby Year Book; 1993:92-4.
23. Laughlin RT, Calhoun JH, Mader JT. The diabetic foot. J Am Acad Ortho Surg. 1995;3:218-25.
24. Brodsky JW. The diabetic foot. In: Mann RA, Coughlin MJ, eds. Surgery of the Foot and Ankle, 6th ed. vol. 2. St. Louis: Mosby; 1993:877-958.
25. Myerson M, Papa J, Eaton K. The total-contact cast for management of neuropathic plantar ulceration of the foot. J Bone Joint Surg Am. 1992;74:261-9.
26. Griffiths GD, Wieman TJ. Metatarsal head resection for diabetic foot ulcers. Arch Surg. 1990;125:832-5.